SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    R.A. Sabroe, Commentary: Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria, British Journal of Dermatology, 2014, 171, 1
  2. 2
    Blake D. Niederhauser, David Dingli, Robert A. Kyle, Michael D. Ringler, Imaging findings in 22 cases of Schnitzler syndrome: characteristic para-articular osteosclerosis, and the “hot knees” sign differential diagnosis, Skeletal Radiology, 2014, 43, 7, 905

    CrossRef

  3. 3
    Antoine Néel, Benoit Henry, Sebastien Barbarot, Agathe Masseau, François Perrin, Claire Bernier, Xavier Kyndt, Xavier Puechal, Pierre-Jean Weiller, Olivier Decaux, Jacques Ninet, Arnaud Hot, Achille Aouba, Leonardo Astudillo, Jean-Marie Berthelot, Fabrice Bonnet, Jean-Marie Brisseau, Bérangère Cador, Fabienne Closs-Prophette, Thomas Dejoie, Jean-Dominique de Korwin, Robin Dhote, Renato Fior, Bernard Grosbois, Eric Hachulla, Pierre-Yves Hatron, Henry Jardel, David Launay, Adrien Lorleac'h, Pierre Pottier, Guillaume Moulis, Jacques Serratrice, Amar Smail, Mohamed Hamidou, Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: A french multicenter study, Autoimmunity Reviews, 2014,

    CrossRef

  4. 4
    Dan Lipsker, Cédric Lenormand, Management of Schnitzler’s syndrome, Expert Opinion on Orphan Drugs, 2014, 2, 9, 947

    CrossRef

  5. 5
    M. Hello, S. Barbarot, A. Néel, J. Connault, J. Graveleau, C. Durant, O. Decaux, M. Hamidou, Manifestations cutanées associées aux gammapathies monoclonales, La Revue de Médecine Interne, 2014, 35, 1, 28

    CrossRef

  6. 6
    Alexander So, Nathalie Busso, The concept of the inflammasome and its rheumatologic implications, Joint Bone Spine, 2014,

    CrossRef

  7. 7
    Hans-Dietmar Beer, Emmanuel Contassot, Lars E French, The Inflammasomes in Autoinflammatory Diseases with Skin Involvement, Journal of Investigative Dermatology, 2014, 134, 7, 1805

    CrossRef

  8. 8
    Torsten Zuberbier, Marcus Maurer, Urticarial Vasculitis and Schnitzler Syndrome, Immunology and Allergy Clinics of North America, 2014, 34, 1, 141

    CrossRef

  9. 9
    Steven Vanderschueren, Daniël Knockaert, Canakinumab in Schnitzler Syndrome, Seminars in Arthritis and Rheumatism, 2013, 42, 4, 413

    CrossRef

  10. 10
    Monika Moll, Jasmin B. Kuemmerle-Deschner, Inflammasome and cytokine blocking strategies in autoinflammatory disorders, Clinical Immunology, 2013, 147, 3, 242

    CrossRef

  11. 11
    A. Simon, B. Asli, M. Braun-Falco, H. Koning, J.-P. Fermand, C. Grattan, K. Krause, H. Lachmann, C. Lenormand, V. Martinez-Taboada, M. Maurer, M. Peters, R. Rizzi, F. Rongioletti, T. Ruzicka, L. Schnitzler, B. Schubert, J. Sibilia, D. Lipsker, Schnitzler's syndrome: diagnosis, treatment, and follow-up, Allergy, 2013, 68, 5
  12. 12
    H. D. de Koning, J. Schalkwijk, J. van der Ven-Jongekrijg, M. Stoffels, J. W. M. van der Meer, A. Simon, Sustained efficacy of the monoclonal anti-interleukin-1 beta antibody canakinumab in a 9-month trial in Schnitzler's syndrome, Annals of the Rheumatic Diseases, 2013, 72, 10, 1634

    CrossRef

  13. 13
    Alexander So, Annette Ives, Leo A. B. Joosten, Nathalie Busso, Targeting inflammasomes in rheumatic diseases, Nature Reviews Rheumatology, 2013, 9, 7, 391

    CrossRef

  14. 14
    Charles A. Dinarello, Jos W.M. van der Meer, Treating inflammation by blocking interleukin-1 in humans, Seminars in Immunology, 2013, 25, 6, 469

    CrossRef

  15. 15
    Daniel Butler, Kanade Shinkai, What Do Autoinflammatory Syndromes Teach About Common Cutaneous Diseases Such as Pyoderma Gangrenosum? A Commentary, Dermatologic Clinics, 2013, 31, 3, 427

    CrossRef

  16. 16
    K. Krause, C. E. Grattan, C. Bindslev-Jensen, M. Gattorno, T. Kallinich, H. D. Koning, H. J. Lachmann, D. Lipsker, A. A. Navarini, A. Simon, C. Traidl-Hoffmann, M. Maurer, How not to miss autoinflammatory diseases masquerading as urticaria, Allergy, 2012, 67, 12